Applied Therapeutics stock (APLT) was down 75% early Friday on news the FDA had declined to approve its drug govorestat, prompting a downgrade by RBC Capital. Read more here.

BellRing Brands has consistently outperformed expectations, delivering strong earnings and robust growth, particularly in its ...

Lam Research is well-positioned for long-term growth due to its leadership in semiconductor technology and strategic focus on ...

Explore the Neuberger Berman Next Generation Connectivity Fund (NBXG) for a tech-heavy, diversified portfolio with potential ...

ExlService Holdings shows strong growth potential, with a 28.21% stock price increase and robust financial performance in Q3.

The company has growing revenues, a strong balance sheet, a high FCF margin, and no major maturities. Click here to read an ...

NetApp's strong Q2 2025 earnings show growth in Hybrid and Public Cloud. Find out why NTAP stock is a buy with its solid ...

CODI's diverse holdings, including high-growth brands like Lugano, contributed significantly to its improved financial ...

Barclays’s global equity derivatives strategy team listed the ETFs with the richest and cheapest volatility.

For the three-month period, financials, health care, and materials detracted from relative performance. Read more here.

HighPeak exceeded production expectations in Q3 '24 but faces challenges in maintaining cash flow and making loan repayments ...

Philip Morris is perhaps the leading cigarette and reduced risk products manufacturer and wholesaler. Click here to read my ...